{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ahn H"],"funding":["National Research Foundation of Korea (NRF)","National Research Foundation of Korea","GIST Research Institute (GRI)"],"pagination":["1896"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9610011"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(10)"],"pubmed_abstract":["Remarkable progress has occurred over the past two decades in identifying microbiomes affecting the human body in numerous ways. The microbiome is linked to gastrointestinal (GI) tract cancer. The purpose of this study was to determine if there is a common microbiome among GI tract cancers and how the microbiome affects the disease. To ensure ethnic consistency, Korean patients with GI tract cancer were selected. <i>Fusobacterium nucleatum</i> is an enriched bacteria in all cancer tissues. <i>F. nucleatum</i> is a Gram-negative obligate anaerobe that promotes colorectal cancer. Through Gene Set Enrichment Analysis (GSEA) and Differentially Expressed Genes (DEG) analyses, the upregulation of the G2M checkpoint pathway was identified in the <i>F. nucleatum</i>-high group. Cell viability and "],"journal":["Microorganisms"],"pubmed_title":["Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: <i>Fusobacterium nucleatum</i> as a Therapeutic Target."],"pmcid":["PMC9610011"],"funding_grant_id":["2022R1A2C2008976"],"pubmed_authors":["Kim S","Park H","Min K","Kim G","Kim H","Jeong C","Kim Y","Ahn H","Cho B","Lee E"],"additional_accession":[]},"is_claimable":false,"name":"Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: <i>Fusobacterium nucleatum</i> as a Therapeutic Target.","description":"Remarkable progress has occurred over the past two decades in identifying microbiomes affecting the human body in numerous ways. The microbiome is linked to gastrointestinal (GI) tract cancer. The purpose of this study was to determine if there is a common microbiome among GI tract cancers and how the microbiome affects the disease. To ensure ethnic consistency, Korean patients with GI tract cancer were selected. <i>Fusobacterium nucleatum</i> is an enriched bacteria in all cancer tissues. <i>F. nucleatum</i> is a Gram-negative obligate anaerobe that promotes colorectal cancer. Through Gene Set Enrichment Analysis (GSEA) and Differentially Expressed Genes (DEG) analyses, the upregulation of the G2M checkpoint pathway was identified in the <i>F. nucleatum</i>-high group. Cell viability and ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2026-04-08T11:38:37.383Z","creation":"2025-05-29T16:10:58.875Z"},"accession":"S-EPMC9610011","cross_references":{"pubmed":["36296174"],"doi":["10.3390/microorganisms10101896"]}}